On-treatment decline in serum HBsAg levels predicts sustained immune control 1 year post-treatment, subsequent I-IBsAg clearance in HBeAg-negative hepatitis B virus- infected patients treated with peginterferon alfa-2a

查看全文 作　　者：Marcellin P; Piratvisuth T; Brunetto M; Bonino F; Farci P; Yurdaydin C; Gurel S; Kapprell HP; Messinger D; Popescu M 出　　处：《Hepatol Int》索引2010年第4卷,共0页